Page last updated: 2024-11-07

dichlororibofuranosylbenzimidazole and Herpes Simplex

dichlororibofuranosylbenzimidazole has been researched along with Herpes Simplex in 1 studies

Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.

Herpes Simplex: A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tigges, MA1
Koelle, D1
Hartog, K1
Sekulovich, RE1
Corey, L1
Burke, RL1

Other Studies

1 other study available for dichlororibofuranosylbenzimidazole and Herpes Simplex

ArticleYear
Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.
    Journal of virology, 1992, Volume: 66, Issue:3

    Topics: Acyclovir; Antigens, Viral; CD8 Antigens; Clone Cells; Cycloheximide; Cytotoxicity, Immunologic; Dac

1992